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Abstract
The conventional cancer stem cell (CSC) theory indicates a hierarchy of CSCs
and non-stem cancer cells (NSCCs), that is, CSCs can differentiate into NSCCs but
not vice versa. However, an alternative paradigm of CSC theory with reversible cell
plasticity among cancer cells has received much attention very recently. Here we
present a generalized multi-phenotypic cancer model by integrating cell plasticity
with the conventional hierarchical structure of cancer cells. We prove that under
very weak assumption, the nonlinear dynamics of multi-phenotypic proportions in
our model has only one stable steady state and no stable limit cycle. This result the-
oretically explains the phenotypic equilibrium phenomena reported in various can-
cer cell lines. Furthermore, according to the transient analysis of our model, it is
found that cancer cell plasticity plays an essential role in maintaining the pheno-
typic diversity in cancer especially during the transient dynamics. Two biological
examples with experimental data show that the phenotypic conversions from NCSSs
to CSCs greatly contribute to the transient growth of CSCs proportion shortly after
the drastic reduction of it. In particular, an interesting overshooting phenomenon of
CSCs proportion arises in three-phenotypic example. Our work may pave the way
for modeling and analyzing the multi-phenotypic cell population dynamics with cell
plasticity.
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1 Introduction
The cancer stem cell (CSC) hypothesis [1, 2] states that tumors or hematological cancers
arise from a small number of stem-like cancer cells with the abilities of self-renewal and
differentiation into other non-stem cancer cells (NSCCs). That is, the conventional cancer
stem cell theory suggests a cellular hierarchy where CSCs are at the apex [3]. Based on
this paradigm, cancer stem cell models were widely investigated in previous literature on
theoretical biology [4, 5, 6, 7, 8, 9, 10, 11, 12, 13].
However, recent studies have highlighted the complexities and challenges in the evolv-
ing concept of CSC [14, 15]. In particular, it was reported that reversible phenotypic
changes can occur between stem-like cancer cells and more differentiated cancer cells.
Meyer et al showed that interconversion occurred both in vivo and in vitro between non-
invasive, epithelial-likeCD44+CD24+ cells and invasive, mesenchymal CD44+CD24−
cells in breast cancer [16]. Chaffer et al showed both in vivo and in vitro that trans-
formed (oncogenic) CD44lo-HMECs (human mammary epithelial cells) could sponta-
neously convert to CD44hi-CSCs [17]. The results by Quintana et al indicated that phe-
notypically diverse cancer cells in both primary and metastatic melanomas can undergo
reversible phenotypic conversions in vivo [18]. Scaffidi et al showed that stem-like cancer
cells can be generated in vitro from transformed (oncogenic) fibroblasts during neoplastic
transformation [19]. The conversion from NSCCs to CSCs was also in situ visualized by
Yang et al in SW620 colon cancer cell line [20]. Besides, the phenotypic transitions be-
tween different NSCCs in breast cancer was reported both in vivo and in vitro [21]. These
various types of phenotypic conversions among cancer cells, also known as cancer cell
plasticity mechanisms [22], provide new thinking about the CSC hypothesis and related
therapeutic strategy [23].
Special attention has recently been paid to the mathematical models concerning can-
cer cell plasticity. Gupta et al introduced a simple Markov chain model of stochastic
transitions among stem-like, basal and luminal cells in breast cancer cell lines [21]. Zap-
peri and La Porta compared mathematical models for cancer cell proliferation that take
phenotypic switching and imperfect biomarker into account [24]. A series of works by
dos Santos and da Silva developed a model with the effects of stochastic noise and cell
plasticity for explaining the variable frequencies of CSCs in tumors [25, 26]. Zhou et al
compared the transient dynamics of the bidirectional and unidirectional models of CSCs
and NSCCs [27]. Wang et al showed that tumor heterogeneity may exist in the model
with both CSC hierarchy and cell plasticity [28]. Leder et al’s model described the re-
versible phenotypic interconversions between the stem-like resistant cells (SLRCs) and
the differentiated sensitive cells (DSCs) in glioblastomas, which revealed optimized radi-
ation dosing schedules [29]. These works demonstrated that cell plasticity provides new
insight into cancer cell population dynamics.
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To further explore how cell plasticity challenges the hierarchical cancer stem cell sce-
nario, and in particular how cell plasticity influences tumor heterogeneity, one should
incorporate cell plasticity into the development of cancer which is full of biological com-
plexities. One particular and crucial complexity arises from highly diverse phenotypes
in the population of cancer cells. The aforementioned mathematical models were mainly
focused on the relation between CSCs and NSCCs [24, 25, 26, 27, 28, 29], that is, their
models simply classified the cancer cells into two “opposite” phenotypes. This simplifi-
cation is effective for studying the reversible conversions between NSCCs and CSCs, but
covers up various phenotype switchings between different cancer cells that are worthy
of studying. As an exceptional case, Gupta et al’s model [21] consists of three pheno-
types (stem-like, basal and luminal cells), but rigorous mathematical analysis for general
multi-phenotypic models with cell plasticity is still lacking.
In this study, we try to provide a multi-phenotypic framework for integrating cell plas-
ticity with conventional growth model of cancer cells. A generalized model comprising
1+m cellular phenotypes (one CSC phenotype and m different NSCC phenotypes) is put
forward. Besides cell-state conversions from NSCCs to CSCs and phenotype switchings
between different NSCC phenotypes, the cellular processes in classical cancer stem cell
models (i.e., asymmetric cell division, symmetric cell division and cell death) are also
included in our model. When the cell population size is not large enough and subject to
stochastic fluctuations, our model is formulated by a continuous-time high-dimensional
Markov process. In the limit of large population size, the model can be governed by
a system of linear ordinary differential equations (ODEs). Moreover, to investigate the
dynamics of phenotypic proportions, the population model is converted into a nonlinear
frequency one. It is shown that under very weak assumption, the nonlinear frequency
model has only one stable steady state and no stable limit cycle. Not only does this
result theoretically explain the phenotypic equilibrium phenomena reported in various
cancer cell lines [17, 20, 21, 30], but it is also predicted that the phenotypic equilibrium
should be universal in the population of multi-phenotypic cancer cells. Furthermore, it
is also found that cancer cell plasticity greatly influences the transient proportions of cell
phenotypes. In particular, two concrete examples with experimental data are presented,
showing that the cell-state conversions play an essential role in the transient growth of
CSCs proportion shortly after the drastic reduction of it. In particular, an interesting
overshooting phenomenon of CSCs proportion arises in S-B-L model with cell plasticity.
Note that two-phenotypic models never perform overshooting [27, 45], overshooting can
be a result of interplay between cell plasticity and diversity of phenotype. Moreover, it
has been investigated in ecology and population genetics that phenotypic variability can
serve as an advantageous strategy for biological populations in fluctuating environments
[31, 32, 33, 34, 35], our findings thus enrich this idea that cell plasticity as a surviving
strategy might be more essential in maintaining the phenotype diversity (heterogeneity)
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of cancer especially during transient dynamics.
The paper is organized as follows. The model framework is formulated in Section 2.
In Section 3, we investigate the frequency model and phenotypic equilibrium. The roles
of cell-state conversions in transient dynamics are discussed in Section 4. Conclusions
are presented in Section 5.
2 Model description
2.1 Assumptions
This section describes the assumptions of the model investigated in this study. Consider
a population of cancer cells comprising 1 +m phenotypes: CSC represents cancer stem
cell, and NSCC1, NSCC2, ..., NSCCm represent m different phenotypes of non-stem can-
cer cells. In this model, cell plasticity is integrated with the growth model of cancer cells.
According to conventional cancer stem cell scenario, not only can CSC divide asymmetri-
cally into two unequal daughter cells (one CSC and one NSCC) [1], but it can also divide
symmetrically into two daughter CSCs [36] 1. So for CSC we assume that
• Symmetric division: CSC α00−→ CSC+CSC;
• Asymmetric division: CSC α0j−→ CSC+NSCCj (1 ≤ j ≤ m);
• Cell death: CSC α0−→ ∅.
For NSCCs, besides the symmetric division, two types of cell plasticity mechanisms that
have been reported in previous biological literature are included in our model, i.e., the cell-
state conversions from NSCCs to CSCs (termed de-differentiation) [20] and phenotype
switchings between different NCSSs [21]. In this way, for NSCCi (1 ≤ i ≤ m) we
assume that
• Symmetric division: NSCCi
αii−→ NSCCi+NSCCi;
• De-differentiation: NSCCi
αi0−→ CSC;
• phenotype switching: NSCCi
αij
−→ NSCCj (i 6= j);
• Cell death: NSCCi
αi−→ ∅.
1It should be noted that, another type of symmetric division that CSC divides into two daughter NSCCs
(termed symmetric differentiation [37]) is not accounted for in our model, however it is shown in 6.6 that
the main results achieved in this study are still valid for the model including symmetric differentiation,
implying the kinetic equivalence between the two models.
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We list the elements of the model in table 1 (see Fig. 1 for the example of three pheno-
types). If we denote X0t , X1t ,..., Xmt as the cell numbers of CSC, NSCC1, ..., NSCCm
at time t respectively, then −→Xt = (X0t , X1t , ..., Xmt )T is an (m + 1)-dimensional cellular
system consisting of (m+ 1)× (m+ 2) cellular processes. On the basis of the modeling
principles in biochemical reactions (see Chapter 7 in [38]), our cellular system can be
formulated by both stochastic and deterministic models as follows:
Table 1: Parameters used in the model
Symbol Parameter Cellular process
α00 symmetric division rate by CSC CSC
α00−→ CSC+CSC
α0j asymmetric division rate by CSC CSC
α0j
−→ CSC+NSCCj (1 ≤ j ≤ m)
α0 death rate by CSC CSC
α0−→ ∅
αii symmetric division rate by NSCCi NSCCi
αii−→ NSCCi+NSCCi (1 ≤ i ≤ m)
αi0 phenotypic conversion rate from NSCCi to CSC NSCCi
αi0−→ CSC (1 ≤ i ≤ m)
αij phenotypic conversion rate from NSCCi to NSCCj NSCCi
αij
−→ NSCCj (i 6= j)
αi death rate by NSCCi NSCCi
αi−→ ∅ (1 ≤ i ≤ m)
2.2 Stochastic model
The randomness of cellular systems is essentially rooted in the stochastic nature of gene
expression in individual cells [39]. The emergence of determinism from randomness
is a result of the Law of Large Numbers. In other words, when the population is not
large enough and subject to stochastic fluctuations, −→X = (X0t , X1t , ..., Xmt )T should be
stochastic. According to the theory of Chemical Master Equation (CME) (see Chapter 11
in [40]), the stochastic model can be formulated by a continuous-time Markov process on
N
m+1
. If we define Pr{x0, ..., xi, ..., xm; t} as the probability of
−→
X = (x0, ..., xi, ..., xm)
T
at time t, then the rate of change in Pr{x0, ..., xi, ..., xm; t} is equal to the rate of transition
from all the other possible states to (x0, ..., xi, ..., xm) minus the rate of transition from
(x0, ..., xi, ..., xm) to all the other possible states, formally,
dPr{x0, ..., xi, ..., xm; t}
dt
= F (x0, ..., xi, ..., xm, t), (1)
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where
F (x0, ..., xi, ..., xm, t) =
m∑
i=0
(xi − 1)αiiPr{x0, ..., xi − 1, ..., xm; t}
+
m∑
i=0
(xi + 1)αiPr{x0, ..., xi + 1, ..., xm; t}
+
m∑
j=1
(x0α0jPr{x0, ..., xj − 1, ..., xm; t})
+
∑
(i,j)∈{1,2,...,m}×{0,1,...,m}
with i 6=j
(xi + 1)αijPr{x0, ..., xi + 1, ..., xj − 1..., xm; t}
−
∑
(i,j)∈{0,1,...,m}×{0,1,...,m}
(xiαij)Pr{x0, ..., xi, ..., xm; t}
−
m∑
i=0
(xiαi)Pr{x0, ..., xi, ..., xm; t}.
The first four items of F (x0, ..., xi, ..., xm, t) describe the transitions from other states to
(x0, ..., xi, ..., xm). For example, the first item corresponds to the sum of the rates of tran-
sition from (x0, ..., xi − 1, ..., xm) to (x0, ..., xi, ..., xm) by symmetric division of ith cell
phenotype, 0 ≤ i ≤ m. Similarly, the other three items can be explained by other types of
cellular processes accordingly. The last two items of F (x0, ..., xi, ..., xm, t) describe the
transitions from (x0, ..., xi, ..., xm) to other states. Since it is difficult to calculate the ana-
lytic solution of Pr{x0, ..., xi, ..., xm; t}, stochastic simulation (called Gillespie algorithm
[41]) can often be used as an efficient numerical approach to investigate the CME.
When the population size is large enough, it is more convenient to use deterministic
equations to capture the model:
2.3 Deterministic model
Let 〈
−→
Xt〉 = (〈X
0
t 〉, 〈X
1
t 〉, ..., 〈X
m
t 〉)
T be the expectation of −→Xt, where
〈X it〉 :=
∑
x0,...,xi,...,xm
xiPr{x0, ..., xi, ..., xm; t} (0 ≤ i ≤ m).
We now derive the equation governing the dynamics of 〈X it〉 (our method is based on
Section 5.8 in [38]). We multiply xi on the both sides of (1), and then calculate the
summation over all the indexes∑
x0,...,xi,...,xm
(xi
dPr{x0, ..., xi, ..., xm; t}
dt
) =
∑
x0,...,xi,...,xm
(xiF (x0, ..., xi, ..., xm, t)),
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that is,
d〈X it〉
dt
=
∑
x0,...,xi,...,xm
(xiF (x0, ..., xi, ..., xm, t)).
Then we have
1) when i = 0
d〈X0t 〉
dt
= (α00 − α0)〈X
0
t 〉+
m∑
i=1
(αi0〈X
i
t〉)). (2)
2) when 1 ≤ i ≤ m
d〈X it〉
dt
=
∑
j 6=i
αji〈X
j
t 〉+ (αii − αi −
∑
j 6=i
αij)〈X
i
t〉. (3)
Thus the dynamics of 〈−→Xt〉 can be formulated by the following (m+1)-dimensional linear
ordinary differential equations (ODEs)
d〈
−→
Xt〉
dt
= A〈
−→
Xt〉, (4)
where
A =


α00−α0 α10 α20 ··· αm0
α01 α11−α1−
∑
j 6=1 α1j α21 ··· αm1
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
α0(m−1) ··· ··· α(m−1)(m−1)−α(m−1)−
∑
j 6=(m−1) α(m−1)j αm(m−1)
α0m ··· ··· α(m−1)m αmm−αm−
∑
j 6=m αmj

 .
(5)
It is noteworthy that Eq. (4) can also be obtained based on the Law of Mass Action (LMA)
[42], indicating the equivalent kinetic foundation between the stochastic theory of CME
and its deterministic counterpart of LMA. If we choose to ignore cancer cell plasticity in
the model, i.e. let αij = 0 (1 ≤ i ≤ m, 0 ≤ j ≤ m, and i 6= j), the form of A will reduce
to the one governing the hierarchical cancer stem cell model:
A∗ =


α00 − α0 0 0 · · · 0
α01 α11 − α1 0 · · · 0
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
α0(m−1) · · · · · · α(m−1)(m−1) − α(m−1) 0
α0m · · · · · · 0 αmm − αm

 . (6)
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In comparison of A and A∗, it is interesting that there seems to be a trade-off between
the diagonal and off-diagonal elements, that is, A has larger off-diagonal elements but
smaller diagonal elements than A∗. Note that the diagonal elements correspond to the
growth contributions from the cells with the same phenotypes themselves while the off-
diagonal elements are the contributions from other phenotypes, cancer cell plasticity can
be interpreted as a altruism behavior among cancer cells in the sense that it makes cancer
cells of one phenotype help other phenotypes to survive by sacrificing their own pheno-
type [43]. How this altruism behavior affects the population structure of cancer cells is
one of the major tasks in the study of cell plasticity models.
In the following two sections, we will analyze both the asymptotic and transient dy-
namics of the model, then apply the theoretical results to explain the problems arising
from concrete biological experiments.
3 Phenotypic equilibrium and frequency model
It has been reported in various cancer cell lines [17, 20, 21, 30] that, the cancer cell
populations starting from different initial proportions can return towards equilibrium pro-
portions over time. The arise of this phenotypic equilibrium has performed as a profound
indication in support of the intrinsic homeostasis in cancer. To explain this phenomenon,
we investigate the dynamics of phenotypic proportions in this section.
The model in previous section describes the population dynamics of the absolute cell
numbers of different phenotypes. However in reality, relative numbers, i.e. the pro-
portions of cell phenotypes are usually measured by fluorescence-activated cell sorting
(FACS) experiments. Thus one often converts the population model to a frequency model.
Let Nt be the total number of the population, Nt = X0t +X1t +...+Xmt , the proportion
of X it is defined as xit = X it/Nt. Then −→xt = (x0t , x1t , ..., xmt )T is the vector describing
the phenotypic proportions. Let 〈−→xt〉 be the expectation of −→xt , from Eq. (4) we can
obtain the nonlinear (second order) ODEs governing the dynamics of 〈−→xt〉 as follows (see
mathematical details in 6.1):
d〈−→xt〉
dt
= A〈−→xt 〉 − 〈
−→xt〉e
TA〈−→xt〉, (7)
where e = (1, 1, ..., 1)T . Note that x0t + x1t + ... + xmt = 1, if replacing xmt by 1 − (x0t +
x1t ...+ x
m−1
t ), the dimension of Eq. (7) should reduce from m+ 1 to m (see 6.1).
To show the stability of the frequency model Eq. (7), we have Theorem 1:
Theorem 1 If the Perron-Frobenius eigenvalue λ1 of the matrix A in Eq. (5) is simple
(i.e. the algebraic multiplicity of λ1 is equal to one), then Eq. (7) has one and only one
stable fixed point and no stable limit cycle.
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(Technically, in very few cases it is necessary to add a small perturbation to the initial
state for completing the final proof, see proof in 6.2)
The Perron-Frobenius eigenvalue λ1 is the largest real eigenvalue satisfying that Reλ < λ1
for every other λ (6.2). On account of the inevitability of perturbations in real world, it can
be proved that almost surely the algebraic multiplicity of λ1 is equal to one (6.3). Espe-
cially when validating the model with biological experiments, the condition of Theorem 1
can easily be satisfied. Theorem 1 thus theoretically explains the phenotypic equilibrium
phenomena observed in cancer cell lines, that is, starting from different initial propor-
tions, the cancer cell population can return towards stable equilibrium proportions as time
passes. Furthermore, note that Theorem 1 holds for the general cases with any finite
phenotypes, it can be predicted that the phenotypic equilibrium should be universal in
multi-phenotypic population of cancer cells.
In next section we will turn our attention from long-term asymptotic behavior to tran-
sient dynamics of the model.
4 Transient analysis and cell plasticity
In this section, we investigate how the cell plasticity influences the transient proportions
of cell phenotypes and maintains the heterogeneity of cancer.
To explore the proportion of any phenotype i (0 ≤ i ≤ m), from Eq. (7) we have
d〈xit〉
dt
=
m∑
j=0
(aij〈x
j
t〉)− 〈x
i
t〉
m∑
n=0
m∑
j=0
(anj〈x
j
t〉). (8)
We are interested in how 〈xit〉 changes shortly after the drastic reduction of it. This prob-
lem is of particular interest to cancer biologists because of two major lines: One is that
in cell culture experiments, they care about the transient changes of cancer cells shortly
after the cell sorting. The other is that they are concerned about how the residual cancer
cells relapse after the treatments.
Assume that the proportion of phenotype i at time t0 becomes very small, i.e. 〈xit0〉 ≈
0. Then Eq. (8) can be approximately simplified as follows
d〈xit〉
dt
∣∣∣∣
t=t0
≈
m∑
j 6=i
(aij〈x
j
t0
〉). (9)
Eq. (9) indicates that the transient growth of 〈xit〉 at time t0 is almost contributed by the
cell-state conversions from other phenotypes provided that current proportion of pheno-
type i is very small. That is, as soon as the cancer cells of one phenotype dramatically
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decreases, cancer cell plasticity helps increase their phenotypic proportion, which serves
as a mutual-helping mechanism in transient dynamics. In particular, suppose the great
majority of CSCs have already been eliminated (e.g. by CSCs-targeted drugs or cell sort-
ing), i.e. 〈x0t0〉 ≈ 0. It is easy to distinguish the conventional CSC model from the one
with cell plasticity by comparing their transient dynamics: In conventional CSC model
without cancer cell plasticity, the growth of CSCs relies only on the self-renewal of CSCs
themselves, the initial growth of CSCs proportion should be very limited (constrained by
the rate limitation of cell division cycle); In contrast, the de-differentiations from other
NSCCs can effectively speed up the transient grow rate of CSCs proportion. In this way,
there should be a disparity of the transient increase between these two models shortly after
the initial time t0. To further illustrate the impact of cell plasticity on transient change of
CSCs proportion, we will discuss two concrete examples in next two subsections: CSC-
NSCC model and S-B-L model.
4.1 CSC-NSCC model
CSC-NSCC model is the most widely studied cell plasticity model. In this model, be-
sides CSCs, all the other non-CSCs are grouped into one whole phenotype. We now treat
the CSC-NSCC model as a two-phenotypic example of the multi-phenotypic framework,
which contains six cellular processes as follows:
1) CSC α00−→ CSC+CSC;
2) CSC α01−→ CSC+NSCC;
3) CSC α0−→ ∅.
4) NSCC α10−→ CSC.
5) NSCC α11−→ NSCC+NSCC;
6) NSCC α1−→ ∅;
Let st be CSCs proportion, and nt = 1 − st be NSCCs proportion, the equation
governing the change of CSCs proportion is then given by
d〈st〉
dt
= −C〈st〉
2 +D〈st〉+ α10, (10)
where C = (α00+α01−α0)−(α11−α1) and D = (α00−α0)−(α11+α10−α1). Note that
α10 is the transition rate from NSCCs to CSCs, the model will reduce to the conventional
CSC model without cell plasticity by letting α10 = 0. Fig. 2 shows the comparison of
the models with and without cell plasticity by validating them to the published data on
SW620 colon cancer cell line [20]. The method for parameter fitting we performed is
presented in 6.4. It is found that the major difference between the two models lies in
purified NSCCs case (Fig. 2A): Starting from very small CSCs proportion (0.6% purity),
10
the initial growth of CSCs proportion predicted by the model without cell plasticity is very
slow, the growth rate will gradually increase until CSCs proportion tends to its equilibrium
level, which shows a typical sigmoidal growth pattern [44]. However, the model with cell
plasticity predicted a transient increase of CSCs proportion shortly after the initiation,
which is in line with the experimental data. Even though both models predict the final
phenotypic equilibrium, only can the model with cell plasticity fit the transient change
on the data. This indicates that cancer cell plasticity could play more essential role in
transient dynamics than in long-term behavior of CSCs proportion. A similar result is
obtained if the stochastic version of the model is simulated using Gillespie algorithm (see
6.5).
4.2 S-B-L model
We now consider a three-phenotypic example of our model. Enlightened by Gupta et al.’s
work [21], the three-phenotypic model comprises of stem-like (S), basal (B) and luminal
cells (L). Based on our framework, S-B-L model contains twelve reactions as follows:
1) S α00−→ S+S;
2) S α01−→ S+B;
3) S α02−→ S+L;
4) S α0−→ ∅.
5) B α11−→ B+B;
6) B α10−→ S;
7) B α12−→ L;
8) B α1−→ ∅;
9) L α22−→ L+L;
10) L α20−→ S;
11) L α21−→ B.
12) L α2−→ ∅;
Let (st, bt, lt)T be the vector describing the proportions of (S, B, L), then we have

d〈st〉
dt
= (α00 − α0)〈st〉+ α10〈bt〉+ α20〈lt〉 − st[A1〈st〉+ A2〈bt〉+ A3〈lt〉]
d〈bt〉
dt
= α01〈st〉+ (α11 − α10 − α12 − α1)〈bt〉+ α21〈lt〉 − 〈bt〉[A1〈st〉+ A2〈bt〉+ A3〈lt〉]
d〈lt〉
dt
= α02〈st〉+ α12〈bt〉+ (α22 − α20 − α21 − α2)〈lt〉 − 〈lt〉[A1〈st〉+ A2〈bt〉+ A3〈lt〉]
(11)
where A1 = α00 + α01 + α02 − α0, A2 = α11 − α1, A3 = α22 − α2. Fig. 3 shows the
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predictions of S-B-L model by fitting to cell-state dynamics on data of SUM159 breast
cancer cell line [21](see methods in 6.4). Starting from very small 〈s0〉, in contrast to the
gradual increase of 〈st〉 predicted by the model with α20 = 0, there is an overshooting of
〈st〉 predicted by the model with α20 > 0, which is in line with the cell-state dynamics
observed in experiment. That is, the proportion of stem-like cells is rapidly elevated
by de-differentiation to the value above the equilibrium level, and then returns towards
the final equilibrium as time passes. It has been reported that CSC-NSCC model can
never perform overshooting [27, 45], which implies that the overshooting phenomenon
are rooted in the diversity of phenotype in the multi-phenotypic model. Moreover, note
that overshooting behavior is a result of biological response to environmental stimulus
through evolution [46], cancer cell plasticity may have meaningful implications for the
evolution of cancer. One possible explanation is that the reversible phenotype switching
between cells provides an advantageous cooperative strategy for cancer cell populations
during their competitions with various anticancer mechanisms [43], thus increases their
collective fitness. This idea is in line with the literature in ecology and population genetics
[32, 34] regarding phenotypic variability as a surviving strategy for biological populations
in fluctuating environments.
5 Conclusions
Instead of the hierarchical structure of cancer cells proposed by cancer stem cell theory,
the updated CSC paradigm with cell plasticity suggests a reversible nature between dif-
ferent cancer cell phenotypes. In this study we proposed a generalized multi-phenotypic
cancer model for providing a mathematical framework to investigate the interplay be-
tween cell plasticity and diversity of phenotypes in cancer. Based on our model, some
interesting and insightful results have been achieved. On one hand, it was shown (in The-
orem 1) that the phenotypic equilibrium phenomena can be predicted by the stability of
our frequency model. On the other hand, by comparing the models with and without cell
plasticity, it was found that cell plasticity may play more essential role in transient dynam-
ics. It has been shown that only can the models with cell plasticity predict the transient
increase and overshooting phenomena in CSCs proportion. In particular, the overshooting
phenomenon performed by the S-B-L model was shown to be one of the salient features
in the multi-phenotypic models with cell plasticity. With the further study of the multi-
phenotypic models with cell plasticity, more interesting and insightful phenomena would
be found in future.
Cancer cell plasticity has enriched the theory of cancer stem cell and comes along with
new fundamental problems in cancer biology: Firstly, its molecular mechanism is poorly
understood. It was reported that TGF-β might have important roles in the process of
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cell-state conversions through activating epithelial mesenchymal transition (EMT) [20].
Further studies on related molecular models should be important tasks. Accordingly, be-
sides the population-level models studied in this work, molecular-level models should
also be accounted for in future. Secondly, even though cell plasticity is found to be inti-
mately related to the heterogeneity of cancer, cancer complexity is a result of multifacto-
rial mechanisms (e.g. clonal evolution, tumor microenvironment, reversible cell plasticity
and etc [47]), and it is not clear in which cancer and to what extent the disease progres-
sion arises from the cell plasticity. That is, how to distinguish cell plasticity from other
sources of cancer heterogeneity should be a central problem in future, for both theoretical
and experimental researchers.
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6 Appendix
6.1 Derivation of Eq. (7)
For Eq. (4)
d〈X it〉
dt
= ai0〈X
0
t 〉+ ai1〈X
1
t 〉+ ... + aim〈X
m
t 〉.
Note that
xit =
X it
X0t +X
1
t + ...+X
m
t
=
X it
Nt
,
d〈X it〉
dt
=
d(〈xit〉〈Nt〉)
dt
= 〈xit〉
d
dt
〈Nt〉+ 〈Nt〉
d〈xit〉
dt
,
then
d〈xit〉
dt
=
1
〈Nt〉
d〈X it〉
dt
−
〈xit〉
〈Nt〉
d〈Nt〉
dt
=
m∑
j=0
(aij〈x
j
t〉)− 〈x
i
t〉
m∑
n=0
m∑
j=0
(anj〈x
j
t〉).
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Then we have Eq. (7).
By letting xmt = 1− (x0t + x1t ... + xm−1t ), we have (for 0 ≤ i ≤ m− 1)
d〈xit〉
dt
=
m∑
j=0
(aij〈x
j
t〉)− 〈x
i
t〉
m∑
n=0
m∑
j=0
(anj〈x
j
t〉)
=
m−1∑
j=0
(aij〈x
j
t〉) + aim〈x
m
t 〉 − 〈x
i
t〉
m∑
n=0
(
m−1∑
j=0
(anj〈x
j
t〉) + anm〈x
m
t 〉
)
=
m−1∑
j=0
(aij − aim)〈x
j
t〉 − 〈x
i
t〉
m∑
n=0
(
m−1∑
j=0
(anj − anm)〈x
j
t〉+ anm
)
+ aim
= −〈xit〉
m∑
n=0
m−1∑
j=0
(anj − anm)〈x
j
t〉︸ ︷︷ ︸
nonlinear term
−〈xit〉
m∑
n=0
anm +
m−1∑
j=0
(aij − aim)〈x
j
t〉︸ ︷︷ ︸
linear term
+aim.︸ ︷︷ ︸
constant term
6.2 Proof of Theorem 1
Let us first consider the properties of Eq. (4). We will show that there exists a largest
real eigenvalue λ1 of A satisfying Reλ < λ1 for every other λ. Note that the off-diagonal
elements of the matrix A are non-negative, A + κI becomes a non-negative matrix (I is
the identity matrix) when κ is large enough. By Perron-Frobenius theory (see chapter 1
in [48]), A + κI has an real eigenvalue λ′1 satisfying Reλ′ < λ′1 for any other eigenvalue
λ′ of A + κI . It is easy to show that λ′1 − κ is just the largest real eigenvalue (called
Perron-Frobenius eigenvalue λ1) satisfying that Reλ < λ1 for every other λ of A 2 .
Suppose λ1 is simple, the solution of Eq. (4) can be expressed as
〈
−→
Xt〉 = c1,1~ue
λ1t +
n∑
j=2
nj∑
l=1
cj,l
nj∑
i=1
~rjl,it
i−1eλjt,
where λ1, λ2, · · ·λn are the different eigenvalues of A, nj is the algebraic multiplicity of
λj , ~u is the normalized (i.e. u0 + u2 + ... + um = 1) right eigenvector of λ1, ~rjl,i is the
corresponding eigenvector of λj , cj,l is a constant determined by initial values. Note that
2If λ′ is an eigenvalue of A+κI , then det|A+κI−λ′I| = 0. For matrix A, we have det|A−(λ′−κ)I| =
0, namely λ′−κ is an eigenvalue of A. Then A has an real eigenvalueλ′
1
−κ satisfying Re(λ′−κ) < λ′
1
−κ
for any other eigenvalue λ′ − κ of A.
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Reλi < λ1 (i 6= 1), when c1,1 6= 0,
〈
−→
Xt〉
c1,1eλ1t
= ~u+
n∑
j=2
nj∑
l=1
cj,l
c1,1
nj∑
i=1
~rjl,it
i−1e(λj−λ1)t → ~u.
Thus
〈−→xt〉 =
〈
−→
Xt〉
〈Nt〉
=
−→
Xt/c1,1e
λ1t
〈Nt〉/c1,1eλ1t
→
~u
u0 + u2 + ... + um
Since ~u has been normalized, 〈−→xt〉 will tend to ~u when t→ +∞.
In the following we will handle the case of c1,1 = 0. Let t = 0, we get the linear
equations of cj,l:
c1,1~u+
n∑
j=2
nj∑
l=1
cj,l
~rjl,1 = 〈
−→
X0〉
T
Denote the coefficient matrix by B = [~u ~r21,1 ~r22,1 · · · ~rnnn,1], and let B∗ be B with its first
column replaced by 〈−→X0〉T . Notice that columns of B are linear independent. Then from
Cramer’s rule
c1,1 =
det|B∗|
det|B|
,
When c1,1 = 0, namely det|B∗| = 0, we can find an n-dimensional vector ~v which is
linear independent with the last n − 1 columns of B. Actually, with a small perturbation
ε~v to 〈
−→
X0〉
T
, all the columns of B∗ are linear independent, and c1,1 6= 0. Note that
fluctuations are inevitable in real world, c1,1 6= 0 always holds in reality.
6.3 The algebraic multiplicity of Perron-Frobenius eigenvalue
It was shown above that the Perron-Frobenius eigenvalue λ1 being simple is essential for
proving Theorem 1. Here we will show that this condition is easily satisfied in real world.
In fact, a more general result can be obtained as follows:
Proposition 1 Denote Rn×n as the space of n × n real square matrices, equipped with
Lebesgue measure. Then its subset of the matrices with repeated eigenvalues has measure
zero.
To prove this proposition, we need following lemma first.
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Lemma 1 For any non-zero polynomial f(x1, x2, · · · , xm) (m ≥ 1), its zero set 3 has
measure 0 (w. r. t. Lebesgue measure on Rm).
Proof of Lemma 1: We use inductive method. For m = 1, the polynomial has
only finite roots, whose zero set has measure 0. Assume we have proved the lemma for
m = k − 1. For m = k, let us take f(x1, x2, · · · , xk) as the polynomial of (x2, · · · , xk),
then the coefficients can be regarded as polynomials of x1. It is easy to see that at most
finite x1 ∈ R can make all coefficients equal to 0. Denote such set of x1 by S, then
{(x1, x2, · · · , xk| x1 ∈ S} has measure 0 in Rk. For any fixed x1 /∈ S, f(x1, x2, · · · , xk)
is a non-zero polynomial of (x2, · · · , xk). From inductive assumption we know its zero set
has measure 0 in Rk−1. By Fubini-Tonelli theorem, we know that {(x1, x2, · · · , xk)| x1 /∈
S, f(x1, x2, · · · , xk) = 0} has measure 0 inRk. Thus {(x1, x2, · · · , xk)| f(x1, x2, · · · , xk) =
0} has measure 0 in Rk.
Proof of Proposition 1: It is easy to show that for any square matrix in Rn×n, the
coefficients of its characteristic polynomial are polynomials of matrix entries. Thus the
discriminant of the characteristic polynomial 4 is again a polynomial of matrix entries.
Applying Lemma 1 to the discriminant of characteristic polynomial, we have that the zero
set of the discriminant has measure zero. And then according to the fact that a polynomial
has repeated root if and only if its discriminant is 0 [49], the set of the matrices with
repeated eigenvalues has measure zero. The proof is completed.
Proposition 1 implies that almost surely the Perron-Frobenius eigenvalue λ1 should
be simple. In particular, perturbations are inevitable in the real work, so λ1 can easily be
simple. To further illustrate this result, we consider a 3× 3 example:
A =

 3 2 30 3 5
0 0 2

 , (12)
its eigenvalues are λ1 = λ2 = 3, λ3 = 2. In this case the Perron-Frobenius eigenvalue λ1
is repeated. However, if adding perturbations to A, e.g.
A =

 3.23 2.19 3.220 3.78 5.11
0 0 2.31

 , (13)
its eigenvalues become λ1 = 3.78, λ2 = 3.23, λ3 = 2.31. In this way the Perron-
Frobenius eigenvalue λ1 become simple.
3 The zero set of f(x1, x2, · · · , xm) is defined as {(x1, x2, · · · , xm) ∈ Rm|f(x1, x2, · · · , xm) = 0}
4The discriminant of m-order polynomial amxm + am−1xm−1 · · ·+ a1x+ a0 is a polynomial function
(see pp. 16-19 in [49]) for concrete form) of its coefficients am, am−1, · · · a1, a0. A polynomial has re-
peated root if and only if its discriminant is 0 [49]. For example, the discriminant of quadratic polynomial
ax2 + bx+ c is b2 − 4ac. ax2 + bx+ c has repeated root if and only if b2 − 4ac = 0.
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Since the perturbations from experimental measurements and natural fluctuations are
inevitable in reality, the Perron-Frobenius eigenvalue λ1 inA is seldom to be repeated. For
example, consider the S-B-L model in Sec 4.2, let α00 = 0.34, α01 = 0.29, α02 = 0.34,
α0 = 0.11, α11 = 0.43, α10 = 0.07, α12 = 0.13, α1 = 0.09, α22 = 0.36, α20 = 0.06,
α21 = 0.17, α2 = 0.10, then the matrix A turns to
A =

 0.23 0.09 0.100.29 0.14 0.06
0.34 0.07 0.03

 . (14)
The eigenvalues of A are λ1 = 0.4391, λ2 = −0.0844, λ3 = 0.0453. The Perron-
Frobenius eigenvalue λ1 is simple.
6.4 Methods for parameter fitting
We used least squares method to estimate the parameters. Let ~y = (y0, ..., yn)T be the
data on n time points, ~x(~θ) = (x0, ..., xn)T be the discrete trajectory of the model with
parameter vector ~θ. The best-fitting parameters are obtained by solving the following least
squares problem
min
~θ
n∑
i=0
(xi − yi)
2.
Specifically, we first discuss the parameter fitting of the CSC-NSCC model to the data
on SW620 cell line [20]. There are four groups of data in their experiment, each group
contains 13 time points (from day 0 to day 24, the data points were recorded every two
days). That is, there are a total of 13× 4 = 52 time points. We estimated the parameters
in Eq. (10) by fitting to these 52 data points of four groups all together. It should be noted
that, based on population-level data measured by FACS experiment, only can we estimate
the values of C, D and α10 in Eq. (10), we cannot estimate all the αij or αi individually.
However, it is interesting that α10 is presented as an independent coefficient, so we can
still compare the models with and without cell plasticity based on the population-level
analysis. We list the main points for parameter fitting as follows:
1. Fit four groups data together: Let yji be the ith time point in jth groups, then we
need to solve the following least squares problem
min
(C,D,α10)
4∑
j=1
12∑
i=0
(xji − y
j
i )
2.
2. Fixed initial states: We set the initial states of Eq. (10) are the same as those on
data, that is, let xj0 = y
j
0 (1 ≤ j ≤ 4).
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3. Parameter range: Based on the rate limitation of human cell proliferation cy-
cle [50], we assume that each cell requires at least one day to finish a cell cycle.
To rescale the discrete time point to continuous time and note that the data was
recorded every two days, we have 0 ≤ αij ≤ 2 log 2. Meanwhile, for the non-
extinction of the cell population, we assume that cell death rate is smaller than
symmetric division rate, i.e. 0 ≤ αi < αii ≤ 2 log 2.
We performed fmincon algorithm in Matlab to calculate optimal values of (C∗, D∗, α∗10).
To test the uniqueness of the solutions, 100 different starting values of (C0, D0, α010) were
uniformly selected on the basis of the above parameter range. It was shown that the
values of (C,D, α10) converge to C∗ ∼ (10−6, 10−5), D∗ = −0.4002 ± 0.0001, and
α∗10 = 0.2630 ± 0.0002. For the goodness of fit, the coefficient of determination is used
to measure how well the observations on data are predicted by the models, that is,
R2 = 1−
SSres
SStot
= 1−
0.0588
0.9921
= 0.9407,
where SSres is the sum of squared residuals and SStot is the total sum of squares (pro-
portional to the sample variance) of data. By letting α10 = 0, with the same numerical
scheme we have C∗ = 1.3865 ± 0.0002, D∗ = 0.9550 ± 0.0001, and the coefficient of
determination is
R2 = 1−
SSres
SStot
= 1−
0.5932
0.9921
= 0.4021.
Fig 2A shows that the disparity between the predictions by the two models mainly lies in
the transient dynamics in purified NSCCs case, where only can the model with α10 > 0
predict the transient increase of CSCs proportion.
Now we discuss the parameter fitting of the S-B-L model. The time-series data we
used is the cell-state dynamics on SUM159 breast cancer cell line (Figure 3 in [21] 5).
There were three cases in their experiments (purified stem-like cells case, purified basal
cells case and purified luminal cells case). In each case, 12 time points were recorded for
each cell phenotype. That is, a total of 3× 12× 3 = 108 data points were recorded. Note
that st + bt + lt = 1, the effective number of the data is actually reduced to 72. By letting
5It should be noted that, this data was produced by discrete-time Markov chain with transition matrix
P =

 0.58 0.35 0.070.01 0.99 0
0.04 0.49 0.47

 . (15)
According to the methods in [21] this cell-state dynamic data was in good line with experimental results on
SUM159 breast cancer cell line.
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lt = 1− st − bt, we have

d〈st〉
dt
= A4〈st〉+ α10〈bt〉+ α20〈lt〉 − st[A1〈st〉+ A2〈bt〉+ A3〈lt〉]
d〈bt〉
dt
= α01〈st〉+ A5〈bt〉+ α21〈lt〉 − 〈bt〉[A1〈st〉+ A2〈bt〉+ A3〈lt〉]
〈lt〉 = 1− st − bt
(16)
where A4 = α00 − α0, A5 = α11 − α10 − α12 − α1. Similar to the CSC-NSCC model, on
the basis of population level data, we cannot estimate all the twelve parameters αij and αi
in S-B-L model individually, since the freedom of the parameters in Eq. (16) is only nine.
Note that the parameters for de-differentiation (α20 and α10) are presented as independent
coefficients, it is feasible to investigate how de-differentiation influences the proportion
of stem-like cells in transient dynamics. By applying similar numerical scheme we used
in the CSC-NSCC model 6, we fitted Eq. (16) to the cell-state dynamics on data. Fig.
4 shows the predictions by the model with α20 = 0, and Fig. 5 shows the predictions
by the model with α20 > 0. Note that the cell-state dynamic data in [21] was produced
by the Markov chain, it is not surprising that the coefficients of determination of the two
models are both close to 1. But it is note worthy that, the main difference between the two
cases lies in the purified luminal case, where only can the model with α20 > 0 predict the
overshooting of stem-like cells proportion.
6.5 Stochastic simulations
The stochastic simulation of CSC-NSCC model is illustrated in Fig. 6. The simulation
scheme we used is based on Monte Carlo simulation for the CME (see Section 11.4.4 in
[40]).
6.6 A remark for the model
By adding symmetric differentiation of CSC into our model,
• CSC β0j−→ NSCCj+NSCCj (1 ≤ j ≤ m)
the dynamics of 〈−→Xt〉 can still be formed by the linear ODEs as follows
d〈
−→
Xt〉
dt
= Q〈
−→
Xt〉, (17)
6Since the time point in S-B-L model was recorded every day, the parameter constraints are changed to
0 ≤ αij ≤ log 2.
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where
Q =


α00−α0−
∑m
j=1 β0j α10 α20 ··· αm0
α01+2β01 α11−α1−
∑
j 6=1 α1j α21 ··· αm1
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
α0(m−1)+2β0(m−1) ··· ··· α(m−1)(m−1)−α(m−1)−
∑
j 6=(m−1) α(m−1)j αm(m−1)
α0m+2β0m ··· ··· α(m−1)m αmm−αm−
∑
j 6=m αmj

 .
(18)
It is easy to find that the only difference between Q and A in Eq. (5) lies in the first
column, but this does not change the non-negativity of the off-diagonal elements. Note
that the main ingredient of the proof of Theorem 1 is the non-negativity of the off-diagonal
elements in A (see 6.2), Theorem 1 still holds for Q.
Moreover, the transient properties discussed in our model are still valid for the model
with Q here, by only replacing aij in Eq. (8) with qij here. Let us take the CSC-NSCC
model as an example. The equation governing the change rate of CSCs proportion is
given by
d〈st〉
dt
= −C∗〈st〉
2 +D∗〈st〉+ α10, (19)
where C∗ = (α00+α01+β01−α0)− (α11−α1) and D∗ = (α00−α0)− (α11+α10−α1).
the property of transient increase is still dependent on α10, which shares the same nature
as Eq. (10).
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Figure 1: The model illustrated by the three-phenotype example (CSC, NSCC1, NSCC2).
For CSC (first row, left to right): symmetric division, asymmetric division (differentiation
to NSCC1), asymmetric division (differentiation to NSCC2), and cell death; For NSCC1
(second row, left to right): symmetric division, phenotypic conversion to CSC, phenotypic
conversion to NSCC2, and cell death; For NSCC2 (third row, left to right): symmetric
division, phenotypic conversion to CSC, phenotypic conversion to NSCC1, and cell death.
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Figure 2: The comparison of CSC-NSCC models (10) with and without cell plasticity
by fitting to experimental data on SW620 colon cancer cell line: The black dots are the
experimental data in [20], the blue dashed lines are the predictions of the model without
cell plasticity (α10 = 0), and the red dashed lines are the predictions of the model with
cell plasticity (α10 > 0). There are four groups of data in the experiment: A) Purified
NSCCs case (0.6% CSCs+99.4% NCSSs); B) 70% CSCs+30% NCSSs; C) Unsorted case
(65.4% CSCs+34.6% NCSSs); D) Purified CSCs case (99.4% CSCs+0.6% NCSSs). By
least squares method, we predicted the values of four different cases together with the
best fitting parameters (see methods in 6.4). It is shown that in (B), (C) and (D), the
predicted trajectories by both models are in good accord with the data. In (A), however,
compared to the sigmoidal growth pattern predicted by the model without cell plasticity,
the prediction by the model with cell plasticity shows a transient increase in the first few
days, which is in line with the experimental data.
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Figure 3: Predictions of S-B-L model: We fitted Eq. (11) to the cell-state dynamics on the
data of SUM159 breast cancer cell line (Figure 3 in [21]). S, B and L are the predictions
by the model, while S∗, B∗ and L∗ are the cell-state dynamics on data. There are three
groups of data: A) Purified stem-like cells case; B) Purified basal cells case; C) Purified
luminal cells case. We predicted the time points of three different cases together with the
best fitting parameters. This figure shows the predictions in purified luminal case, see 6.4
for the other two cases. The left panel is the predictions by the model without phenotypic
conversion from luminal cells to stem-like cells (α20 = 0), while the right panel is the
predictions by the model with phenotypic conversion from luminal cells to stem-like cells
(α20 > 0). It is shown that only can the model with cell plasticity predict the overshooting
of the proportion of stem-like cells. The small window in left panel specifically focuses
on the overshooting phenomenon of stem-like cells.
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A. Purified stem−like cells case
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Figure 4: Fit Eq. (16) to cell-state dynamics in [21] by letting α20 = 0. The best fitting
parameters are A4 = 0.032± 0.002, α10 = 0.016± 0.003, α20 = 0, A1 = 0.578± 0.002,
A2 = 0.581 ± 0.002, A3 = 0.550 ± 0.001, α01 = 0.416 ± 0.001, A5 = 0.567 ± 0.002
and α21 = 0.693 ± 0.001. The sum of squared residuals SSres are about 0.06 and the
coefficient of determinationR2 = 0.9851. The unfitting part lies in the transient dynamics
of the purified luminal cells case. In particular, the overshooting of the stem-like cells
proportion cannot be predicted by the model.
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0 1 2 3 4 5 6 7 8 9 10 11
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Time
B. Purified basal cells case
 
 
0 1 2 3 4 5 6 7 8 9 10 11
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Time
C. Purified luminal cells case
 
 
S*
B*
L*
S
B
L
Figure 5: Fit Eq. (16) to cell-state dynamics in [21] by letting α20 > 0. The best fitting
parameters are A4 = 0.027 ± 0.002, α10 = 0.013 ± 0.001, α20 = 0.071 ± 0.001, A1 =
0.580 ± 0.002, A2 = 0.578 ± 0.002, A3 = 0.579 ± 0.001, α01 = 0.418 ± 0.001, A5 =
0.567 ± 0.003, and α21 = 0.688 ± 0.001. The sum of squared residuals is about ∼
(10−7, 10−8), so the coefficient of determination R2 is very close to 1.
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Figure 6: Stochastic simulation of CSC-NSCC model: It is shown that starting from very
small CSCs proportion, the stochastic model without cell plasticity shows sigmoidal pat-
tern growth, while the model with cell plasticity predicts the transient increase of CSCs
proportion. This is in accord with the prediction by the Eq. (10) in Fig. 2A. The small
window shows the strategy of our stochastic simulation. For given parameters, 20 stochas-
tic samples (colorful thin lines) were produced by Monte carlo simulation. The thick black
line is the representative trajectory by averaging these 20 stochastic samples.
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